- Potential efficacy of abatacept vs adalimumab in RA treatment compared.
- Study involved 342 UK patients across 53 centers.
- Genetic backgrounds showed no significant difference in treatment outcomes.
- Drug-naïve status was a stronger predictor of response.
- Need for larger studies to confirm these findings.
Source: Arthritis and Rheumatology
